The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Potential pitfalls of CRISPR/Cas9‐mediated genome editing
Abstract
Recently, a novel technique named the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR‐associated protein (Cas)9 system has been rapidly developed. This genome editing tool has improved our ability tremendously with respect to exploring the pathogenesis of diseases and correcting disease mutations, as well as phenotypes. With a short guide RNA, Cas9 can be precisely directed to target sites, and functions as an endonuclease to efficiently produce breaks in DNA double strands. Over the past 30 years, CRISPR has evolved from the ‘curious sequences of unknown biological function’ into a promising genome editing tool. As a result of the incessant development in the CRISPR/Cas9 system, Cas9 co‐expressed with custom guide RNA s has been successfully used in a variety of cells and organisms. This genome editing technology can also be applied to synthetic biology, functional genomic screening, transcriptional modulation and gene therapy. However, although CRISPR/Cas9 has a broad range of action in science, there are several aspects that affect its efficiency and specificity, including Cas9 activity, target site selection and short guide RNA design, delivery methods, off‐target effects and the incidence of homology‐directed repair. In the present review, we highlight the factors that affect the utilization of CRISPR/Cas9, as well as possible strategies for handling any problems. Addressing these issues will allow us to take better advantage of this technique. In addition, we also review the history and rapid development of the CRISPR/Cas system from the time of its initial discovery in 2012.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The commonly used SpCas9 is ~4.2 kb, so a single AAV (~4.5 kb) is not sufficient to fit all the necessary CRISPR components [25].”
From Viral Delivery Systems for CRISPR (2019) · cites this paper as [25]
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993
Kim, S., Kim, D., Cho, S. W., Kim, J., & Kim, J.-S. (2014) · Genome Research · doi:10.1101/gr.171322.113 · Cited by 1,856
Flagged first, then by citations
Research works printed but not linked: 59
- 10.1002/yea.1478 · DOI
- 10.1126/science.2660260 · DOI
- 10.1126/science.1178817 · DOI
- 10.1128/jb.169.12.5429-5433.1987 · DOI · Paper page
- 10.1007/s00239-004-0046-3 · DOI · Paper page
- 10.1046/j.1365-2958.2002.02839.x · DOI · Paper page
- 10.1128/JCM.41.1.15-26.2003 · DOI
- 10.1099/mic.0.28048-0 · DOI · Paper page
- 10.1126/science.1138140 · DOI · Paper page
- 10.1126/science.1159689 · DOI · Paper page
- 10.1126/science.1192272 · DOI
- 10.1038/nrmicro2577 · DOI · Paper page
- 10.1038/nature10402 · DOI
- 10.4161/rna.24321 · DOI · Paper page
- 10.1038/nature13011 · DOI · Paper page
- 10.1038/nbt.2884 · DOI · Paper page
- 10.1038/nbt.3198 · DOI · Paper page
- 10.1038/srep09592 · DOI
- 10.1186/s12977-015-0150-z · DOI
- 10.1093/femsyr/fov004 · DOI
- 10.1038/nmeth.3580 · DOI
- 10.7554/eLife.00471 · DOI · Paper page
- 10.1038/cr.2013.46 · DOI · Paper page
- 10.1073/pnas.1313587110 · DOI · Paper page
- 10.1038/nmeth.3473 · DOI
- 10.1126/science.1246981 · DOI · Paper page
- 10.1101/gr.191452.115 · DOI · Paper page
- 10.1038/nmeth.3543 · DOI · Paper page
- 10.1038/nbt.3026 · DOI · Paper page
- 10.7554/eLife.04766 · DOI · Paper page
- 10.1016/S1074-7613(01)00144-3 · DOI
- 10.1038/nbt.3081 · DOI · Paper page
- 10.1002/anie.201506030 · DOI · Paper page
- 10.1101/gr.163394.113 · DOI
- 10.1038/nmeth.3075 · DOI · Paper page
- 10.1261/rna.051631.115 · DOI
- 10.1111/febs.13110 · DOI
- 10.1038/nmeth.3284 · DOI · Paper page
- 10.1038/nmeth.2857 · DOI · Paper page
- 10.1038/srep11221 · DOI
- 10.1038/nbt.2909 · DOI · Paper page
- 10.1038/nbt.2908 · DOI · Paper page
- Tomkinson AE, 2013, DNA ligases as therapeutic targets, Transl Cancer Res, 2
- 10.1186/s13073-015-0215-6 · DOI
- 10.1073/pnas.1502370112 · DOI
- 10.1016/j.stem.2015.01.003 · DOI · Paper page
- 10.1111/febs.13416 · DOI
- 10.1016/j.cell.2012.11.054 · DOI
- 10.1073/pnas.1515692112 · DOI
- 10.1056/NEJMoa1502214 · DOI · Paper page
- 10.1016/j.cell.2015.06.059 · DOI · Paper page
- 10.1007/s13238-015-0153-5 · DOI · Paper page
- 10.1093/nar/gkm349 · DOI
- 10.1093/bioinformatics/btu743 · DOI
- 10.1093/bioinformatics/btu048 · DOI · Paper page
- 10.1093/nar/gku410 · DOI
- 10.1038/nmeth.2812 · DOI
- 10.1371/journal.pone.0119372 · DOI
- 10.1093/bioinformatics/btv423 · DOI
Cited by
Sorted by citations
CRISPR/cas9 genome editing in wheat
Kim, D., Alptekin, B., & Budak, H. (2018) · Functional & Integrative Genomics · doi:10.1007/s10142-017-0572-x · Cited by 365
CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool
Brokowski, C., & Adli, M. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.05.044 · Cited by 320
Viral Delivery Systems for CRISPR
Xu, C. L., Ruan, M. Z. C., Mahajan, V. B., & Tsang, S. H. (2019) · Viruses · doi:10.3390/v11010028 · Cited by 277
Current status and perspectives of genome editing technology for microalgae
Jeon, S., Lim, J.-M., Lee, H.-G., Shin, S.-E., Kang, N. K., Park, Y.-I., Oh, H.-M., Jeong, W.-J., Jeong, B.-R., & Chang, Y. K. (2017) · Biotechnology for Biofuels · doi:10.1186/s13068-017-0957-z · Cited by 154
Genome Editing Weds CRISPR: What Is in It for Phytoremediation?
Basharat, Z., Novo, L. A. B., & Yasmin, A. (2018) · Plants · doi:10.3390/plants7030051 · Cited by 104
Metadata
- Authors
- Peng, R., Lin, G., & Li, J.
- Affiliations
- National Center for Clinical Laboratories Beijing Hospital Beijing China
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2015-11-27
- Volume
- 283
- Issue
- 7
- Pages
- 1218-1231
- ISSN
- 1742-464X
- 1742-4658
- Cited by
- 213
- References
- 21
- Language
- en
- Funders
- Beijing Municipal Public Health Bureau (2011-4011-02)
- National Population and Family Planning Commission of the People's Republic of China (201402018)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review